View Older Stories View More Recent Stories
-
WSFS Strengthens Executive Leadership Team to Support Next Phase of Growth
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
OneConnect Financial (OCFT) PT Lowered to $5.56 at Citi
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Hannon Armstrong (HASI) PT Maintained at $24 at Citi
-
Form 424B2 CITIGROUP INC
-
Citi on Lam Research (LRCX): 'our #1 equipment pick'
-
Sabra Healthcare REIT Inc. (SBRA) PT Raised to $15 at Citi
-
Midday movers: Microsoft, Xpeng rise; Palo Alto, Keysight fall
-
Citi Reiterates Neutral Rating on Vodafone Idea Ltd. (IDEA:IN)
-
HSBC Continental Europe: Pre Stabilisation Notice
-
Delhivery Ltd (DELHIVER:IN) PT Lowered to INR500 at Citi
-
This chipmaker remains a "top pick" for Citi analysts. Here's why
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 4 Citi Trends Inc For: May 17 Filed by: Makuen David N.
-
Form 4 Citi Trends Inc For: May 17 Filed by: Powell Lisa A.
-
Form 4 Citi Trends Inc For: May 17 Filed by: Plutino Heather L
-
Form 4 Citi Trends Inc For: May 17 Filed by: Bhargava Vivek
-
The American "Digital Ghost": Lack of Financial Footprint Locks Millions Out of the Modern Economy, Socure Research Shows
-
The Robert G. Wilmers Integrity Prize Appoints Three New Members to its Board of Directors
-
Form 424B2 CITIGROUP INC
-
Trip.com Group Limited (TCOM) PT Raised to $66 at Citi
-
Alcoa (AA) PT Raised to $50 at Citi
-
Bread Financial Holdings (BFH) Appoints John J. Fawcett to its Board
-
John J. Fawcett Appointed to Bread Financial™’s Board of Directors
-
Palo Alto Networks (PANW) PT Raised to $345 at Citi, 'We Said It’d Be Bumpy'
-
Citius Pharmaceuticals (CTXR) Achieves Primary and Secondary Endpoints in Phase 3 Trial of Mino-Lok Antibiotic Lock Solution
-
Here's what to expect when Target reports earnings
-
Citius Pharmaceuticals Achieves Primary and Secondary Endpoints in Phase 3 Trial of Mino-Lok Antibiotic Lock Solution
-
Citius Pharmaceuticals (CTXR) Halted, News Pending
-
Citi Trends Sets Date for First Quarter 2024 Earnings Release and Conference Call
-
Citi Reiterates Buy Rating on Bristol-Myers Squibb Co. (BMY)
-
Form 424B2 CITIGROUP INC
-
Citi Reiterates Buy Rating on Snowflake Inc. (SNOW)
-
Citi Opens 30-Day Upside Catalyst Watch on Gap, Inc. (GPS)
-
Immersive Labs Unveils New ‘Dark Side of GenAI’ Report about How People Trick Chatbots into Exposing Company Secrets
-
Citi Reiterates Buy Rating on Gap, Inc. (GPS)


